|
?:authorAffiliation
|
-
[\'Department of Oncology and Hemato-Oncology, Division of Early Drug Development, European Institute of Oncology, IRCCS and University of Milano, Milan, Italy. Electronic address: clinicalguidelines@esmo.org.\', \'Gynaecology Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK.\', \'Department of Medical Oncology, Biomedical Research Institute, INCLIVA, University of Valencia, Valencia, Spain; Hematology and Medical Oncology, CIBERONC Instituto de Salud Carlos III, Madrid, Spain.\', \'Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.\', \'Medical Oncology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.\', \'Thoracic Oncology, Université de Lyon, Université Claude Bernard Lyon, Lyon, France; Thoracic Surgery, Département Oncologie Médicale, Institut Curie, Paris, France.\', \'Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.\', \'Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.\', \'Department of Institut Roi Albert II, University Cancer Center Leipzig, Leipzig University Medical Center, Leipzig, Germany.\', \'Institut Roi Albert II, Service d\'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (POLE MIRO), Université Catholique de Louvain, Brussels, Belgium.\', \'Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.\', \'Department of Medical Oncology, Vall d\'Hebron University Hospital and Vall d\'Hebron Institute of Oncology (VHIO), Barcelona, Spain.\', \'Department of Medical Oncology, Centre René Gauducheau, Nantes, France.\', \'Department of Medical Oncology, Medical School, University of Ioannina, Ioannina, Epirus, Greece.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}